STAT3 has been considered as a valuable therapeutic target in glioma because (i) multiple signalling pathways changed in glioma converge to STAT3 and (ii) it involves in multiple characteristics of glioma aggressiveness, via regulation of genes especially implicated in cell proliferation, growth, apoptosis, migration, invasion and neoangiogenesis 38. Here, STAT3 is linked to central nervous system cancer.